FDA ADVISORY-COMMITTEE SYSTEM EVALUATED

被引：0

作者：

不详

机构：

来源：

LANCET | 1993年 / 341卷 / 8836期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：45 / 45

页数：1

共 50 条

[1] IOM ENDORSES FDA ADVISORY-COMMITTEE SYSTEM
FOX, JL
[J]. BIO-TECHNOLOGY, 1993, 11 (02): : 154 - 155
[2] FDA ARTHRITIS ADVISORY-COMMITTEE MEETING
PAULUS, HE
[J]. ARTHRITIS AND RHEUMATISM, 1982, 25 (05): : 595 - 596
[3] FDA ARTHRITIS ADVISORY-COMMITTEE MEETING
PAULUS, HE
[J]. ARTHRITIS AND RHEUMATISM, 1982, 25 (09): : 1124 - 1125
[4] FDA ARTHRITIS ADVISORY-COMMITTEE MEETING
PAULUS, HE
[J]. ARTHRITIS AND RHEUMATISM, 1983, 26 (10): : 1288 - 1289
[5] SELECTION OF FDA ADVISORY-COMMITTEE MEMBERS
PODELL, LB
[J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1983, 40 (10): : 1614 - 1614
[6] FDA ARTHRITIS ADVISORY-COMMITTEE MEETING
PAULUS, HE
[J]. ARTHRITIS AND RHEUMATISM, 1985, 28 (04): : 450 - 451
[7] FDA ADVISORY-COMMITTEE RECOMMENDS EARLIER USE OF ZIDOVUDINE
不详
[J]. CLINICAL PHARMACY, 1990, 9 (04): : 248 - 248
[8] FDA ARTHRITIS ADVISORY-COMMITTEE MEETING - THERAFECTIN - ROLE OF ARTHRITIS ADVISORY-COMMITTEE IN FDA REVIEW PROCESS - PERSONNEL CHANGES - ISSUES OF OVER-THE-COUNTER SWITCHING
FURST, DE
PAULUS, HE
[J]. ARTHRITIS AND RHEUMATISM, 1994, 37 (09): : 1408 - 1409
[9] FUNDAMENTALLY SOUND FDA ADVISORY-COMMITTEE SYSTEM EXPECTS TO USE MOST IMPROVEMENT IDEAS
MARWICK, C
GUNBY, P
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (02): : 198 - 198
[10] ADVISORY-COMMITTEE ON PESTICIDES
CHALLIS, T
[J]. FOOD AND CHEMICAL TOXICOLOGY, 1991, 29 (09) : 649 - 650